Exosomes – tiny biological nanoparticles which transfer information between cells – offer significant potential in detecting and treating disease, the most comprehensive overview so far of research in the field has concluded.
Areas which could benefit include cancer treatment and regenerative medicine, say Dr Steven Conlan from Swansea University, Dr Mauro Ferrari of Houston Methodist Research Institute in Texas, and Dr Inês Mendes Pinto from the International Iberian Nanotechnology Laboratory in Portugal. Their commissioned paper, Exosomes as Reconfigurable Therapeutic Systems, is published today by Cell Press in Trends in Molecular Medicine.
Exosomes are particles produced by all cells in the body and are from 30-130 nanometres in size – a nanometre is one-billionth of a metre. They act as biological signalling systems, communicating between cells, carrying proteins, lipids, DNA and RNA. They drive biological processes, from modulating gene expression to transmitting information through breast milk.
Though discovered in 1983, the full potential of exosomes is only gradually being revealed. The researchers show that the nanoparticles’ possible medical benefits fall into three broad categories:
- Detecting disease – by acting as disease-specific biomarkers
- Activating immune responses to boost immunity
- Treating diseases – serving as the vehicle for drugs, for example bearing cancer therapies as their payload, to target tumours
One of the most useful properties of exosomes is that they are able to cross barriers such as the plasma membrane of cells, or the blood/brain barrier. This makes them well-suited to delivering therapeutic molecules in a very targeted way.
The potential benefits of exosomes can be seen in the wide range of research projects – cited in the paper – already either completed or under way, in areas such as:
- Improved testing for prostate cancer
- A small-cell lung cancer trial
- Stem cell-derived exosomes strengthening heart muscles
- Regeneration of muscle and tissue
The team caution that there is more to do before research into exosomes translates into new techniques and treatments. Side-effects need to be considered, and a standardised approach to isolating, characterising and storing exosomes will need to be developed.
Researchers will also need to ensure that the properties of exosomes do not end up causing harm: for example they can transfer drug resistance and pacify the immune system.
Nevertheless, the potential is very clear, with the team describing exosomes as “increasingly promising”.
Professor Steve Conlan of Swansea University Medical School, one of the authors of the paper, said:
“Our survey of research into exosomes shows clearly that they offer enormous potential as a basis for detecting and treating disease.
Further studies are necessary to turn this research into clinical outcomes, but researchers and funders should be very encouraged by our findings. Our own research in Swansea is investigating the use of exosomes and exosome-like synthetic nanoparticles in combatting ovarian and endometrial cancer.
Progress in this field depends on partnership. As the authorship of our own paper illustrates, researchers in different countries are increasingly working together in nanohealth. Swansea University has wider links with Houston and Portuguese based researchers in the field.
It’s also important to build partnerships outside academia, in particular with government and companies in this fast-growing sector.”
The Latest on: Exosomes
Repurposed drugs may halt the spread of cancer cells
on July 11, 2018 at 6:05 am
One way they do this is through chemical messages delivered in exosomes, the molecules that carry information from cell to cell. Currently there are no known drugs that selectively target and inhibit ... […]
Liquid Biopsy Market Size Worth $5.96 Billion by 2030 | CAGR 13.4%: Grand View Research, Inc.
on July 11, 2018 at 6:03 am
Browse full research report with TOC on "Liquid Biopsy Market Size, Share & Trends Analysis Report By Application, By Sample Type (Blood, Urine) By Biomarker Type (CTC, ctDNA, Exosomes), By Technology ... […]
Mitochondrial DNA in exosomes is the alarm that initiates the antiviral response
on July 10, 2018 at 3:35 am
Researchers at the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) have provided valuable information about the defense mechanisms of the immune system during the early stages of ... […]
Global Exosomes Market 2018-2023: Technical Difficulties with the Implementation and Usage of Exosomes
on May 14, 2018 at 5:00 pm
The "Global Exosomes Market - Segmented by Isolation Method, Downstream Analysis, Application, and Geography - Growth, Trends, and Forecast (2018 - 2023)" report has been added to ResearchAndMarkets.c... […]
Global Exosomes Market Challenges & Industry Analysis by 2018-2025
on April 12, 2018 at 1:11 pm
Brooklyn, NY -- (SBWIRE) -- 04/12/2018 -- Qyresearchreports include new market research report "Global Exosomes Market Size,Status and Forecast 2025" to its huge collection of research reports. This r... […]
Researchers invent novel RNA nanotech to decorate exosomes for effective cancer therapy
on December 11, 2017 at 1:42 pm
A new study shows that attaching antibody-like RNA nanoparticles to microvesicles can deliver effective RNA therapeutics such as small interfering RNA (siRNA) specifically to cancer cells. Researchers ... […]
Analysis of extracellular vesicles including exosomes by imaging flow cytometry
on June 22, 2016 at 5:00 am
This webinar was originally scheduled for broadcast on June 8, but was postponed due to technical issues. Extracellular vesicles (EVs) such as exosomes (70 nm – 160 nm in diameter) and microvesicles ( ... […]
Deploying exosomes to win a battle of the sexes
on August 24, 2014 at 5:00 pm
Male fruit flies deploy exosomes to alter the mating behavior of females. Shown here, a close-up view (right) of the female reproductive tract (left) reveals a green exosome (arrow) on the surface. Cr... […]
Are Exosomes the Next PD-1 in Cancer Research?
on April 30, 2014 at 7:03 am
Whitefish, MT / April 30, 2014 / PD-1, or programmed death protein 1, is certainly a hot button in the field of oncology, with the new immune checkpoint inhibitors pegged by many as part of a wave of ... […]
Exosomes Shine a Light on Alzheimer’s Disease and CTE
on April 3, 2014 at 7:57 am
WHITEFISH, MT / April 3, 2014 Concussions are common in recreational and professional sports with an estimated 1.6 million sustained concussion-related injuries per year in the U.S. alone. Since concu... […]
via Google News and Bing News